Abstract
Chemotherapy, not androgen receptor-targeted therapy should be used upfront for metastatic hormone-sensitive prostate cancer. PRO: docetaxel chemotherapy should be the default consideration in metastatic hormone-sensitive prostate cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have